In Good Company with Nicolai Tangen HIGHLIGHTS: Thomas Schinecker - CEO of Roche
7 snips
Nov 22, 2024 
Thomas Schinecker, CEO of Roche, shares insights on the forefront of cancer treatment and personalized medicine. He discusses the transformative role of AI in drug discovery and the groundbreaking advancements in diagnostics. Schinecker highlights challenges faced by Europe in clinical trials as it struggles to keep pace with China’s fast-evolving pharma industry. Additionally, he addresses the complex balance between drug pricing and innovation, emphasizing the critical responsibility of pharmaceutical leaders in improving patient health.
AI Snips
Chapters
Books
Transcript
Episode notes
Cancer Treatment Breakthroughs
- Understanding the human genome revolutionized cancer treatment, enabling targeted therapies.
- Advancements like antibodies and immunotherapies significantly improved cancer survival rates.
Drug Development Challenges and Successes
- Roche has launched approximately two new medicines annually for the past 10-15 years.
- Developing new medicines takes around 13 years, with a 10% success rate from development to launch.
Brain Shuttle Technology
- Brain shuttle technology allows larger molecules to bypass the blood-brain barrier, opening new possibilities for treating brain diseases.
- Roche is developing a promising Alzheimer's medicine using this technology, aiming for launch by 2028-2029.
